XML 112 R47.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Intangible assets (Tables) | 12 Months Ended
--- | ---
Nov. 30, 2023
Disclosure of detailed information about intangible assets [abstract] |
Schedule of Intangible Assets |
|  |  |  | Commercialization rights – Trogarzo ® North American Territory |  |  | Commercialization rights – Trogarzo ® European Territory |  |  | Commercialization rights – EGRIFTA SV ® |  |  | Oncology platform |  |  | Total |
|  | Cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Balance as at November 30, 2021 |  |  | $ 11,972 |  |  |  | $ 7,612 |  |  |  | $ 14,041 |  |  |  | $ 3,488 |  |  |  | $ 37,113 |
|  | Additions |  |  | 2,832 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 2,832 |
|  | Balance as at November 30, 2022 |  |  | $ 14,804 |  |  |  | $ 7,612 |  |  |  | $ 14,041 |  |  |  | $ 3,488 |  |  |  | $ 39,945 |
|  | Disposal |  |  | - |  |  |  | (7,612) |  |  |  | - |  |  |  | - |  |  |  | (7,612) |
|  | Balance as at November 30, 2023 |  |  | $ 14,804 |  |  |  | $ - |  |  |  | $ 14,041 |  |  |  | $ 3,488 |  |  |  | $ 32,333 |
|  | Accumulated amortization |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Balance as at November 30, 2021 |  |  | $ 3,267 |  |  |  | $ 999 |  |  |  | $ 11,459 |  |  |  | - |  |  |  | $ 15,725 |
|  | Amortization |  |  | 1,087 |  |  |  | 6,613 |  |  |  | 1,511 |  |  |  | - |  |  |  | 9,211 |
|  | Balance as at November 30, 2022 |  |  | $ 4,354 |  |  |  | $ 7,612 |  |  |  | $ 12,970 |  |  |  | - |  |  |  | $ 24,936 |
|  | Disposal |  |  | $ - |  |  |  | (7,612) |  |  |  | - |  |  |  | - |  |  |  | (7,612) |
|  | Amortization |  |  | $ 1,442 |  |  |  | $ - |  |  |  | $ 1,071 |  |  |  | - |  |  |  | $ 2,513 |
|  | Balance as at November 30, 2023 |  |  | $ 5,796 |  |  |  | $ - |  |  |  | $ 14,041 |  |  |  | - |  |  |  | $ 19,837 |
|  | Net carrying amounts |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | November 30, 2023 |  |  | $ 9,008 |  |  |  | $ - |  |  |  | $ - |  |  |  | $ 3,488 |  |  |  | $ 12,496 |
|  | November 30, 2022 |  |  | $ 10,450 |  |  |  | $ - |  |  |  | $ 1,071 |  |  |  | $ 3,488 |  |  |  | $ 15,009 |
Schedule of Commercial Milestone Payment | As further consideration under the TaiMed Agreement, the Company shall make the following one-time payments upon the first occurrence of the following commercial events:
Commercial milestone |  | Commercial milestone payment |
(i) Upon first achieving annual net sales of $200,000 |  |  | $10,000 |
(ii) Upon first achieving annual net sales of $500,000 |  |  | $40,000 |
(iii) Upon first achieving annual net sales of $1,000,000 |  |  | $100,000 |

X
- Definition The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 38 -IssueDate 2023-01-01 -Paragraph 118 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfIntangibleAssetsAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Detailed Information About In Commercial Milestone Payment Explanatory + References No definition available. + Details
Name: | thtx_DisclosureOfDetailedInformationAboutInCommercialMilestonePaymentExplanatoryTextBlock
Namespace Prefix: | thtx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration